Dov Gertz

Dov Gertz is a co-founder of Converge Bio, a company operating in the biotechnology research sector. Converge Bio the Generative AI Lab for the Life Sciences. Based in Tel Aviv-Yafo, Tel Aviv, Israel, Dov leads the company's strategic vision and day-to-day operations.

Under Dov's leadership, Converge Bio recently secured $25M in Series A funding on Jan 13, 2026, backed by investors including Bessemer Venture Partners. This funding milestone reflects strong investor confidence in both the founding team's execution capabilities and the company's market opportunity.

With fresh capital, Dov and the team are focused on scaling operations, expanding the product roadmap, and building out a world-class team. The biotechnology research market continues to see significant investment activity, positioning Converge Bio to capitalize on growing demand.For vendors and partners, this represents an ideal window to engage.